Phase 1 Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers

被引:0
|
作者
Merica, VarshaIyer Elizabeth
Ronseaux, Sebastien
Gamache, Tressa
Mulrow, Nancy J.
Belcijan, Anja
Callaghan, Michael U.
机构
[1] Agios Pharmaceut Inc, Cambridge, MA USA
[2] Merica Clin Consulting, Boston, MA USA
[3] Mulrow & Associates Consulting LLC, Boston, MA USA
[4] PPD Pharmaceut, Barcelona, Spain
关键词
D O I
10.1182/blood-2021-148381
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2043
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Results from the Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers
    Gurov, Xiaoshu Dai
    Merica, Elizabeth
    Iyer, Varsha
    Claeys, Annie
    Patil, Spurthi
    Urbstonaitis, Rolandas
    Xiao, James
    Callaghan, Michael U.
    BLOOD, 2022, 140 : 5426 - 5427
  • [2] Ascending-Dose Study of Noribogaine in Healthy Volunteers: Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability
    Glue, Paul
    Lockhart, Michelle
    Lam, Fred
    Hung, Noelyn
    Hung, Cheung-Tak
    Friedhoff, Lawrence
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (02): : 189 - 194
  • [3] Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers
    Butler, Kathleen
    Teng, Renli
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (01) : 65 - 77
  • [4] Vedolizumab Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability Following Administration of a Single, Ascending, Intravenous Dose to Healthy Volunteers
    Maria Rosario
    Timothy Wyant
    Timothy Leach
    Serap Sankoh
    Catherine Scholz
    Asit Parikh
    Irving Fox
    Brian G. Feagan
    Clinical Drug Investigation, 2016, 36 : 913 - 923
  • [5] Vedolizumab Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability Following Administration of a Single, Ascending, Intravenous Dose to Healthy Volunteers
    Rosario, Maria
    Wyant, Timothy
    Leach, Timothy
    Sankoh, Serap
    Scholz, Catherine
    Parikh, Asit
    Fox, Irving
    Feagan, Brian G.
    CLINICAL DRUG INVESTIGATION, 2016, 36 (11) : 913 - 923
  • [6] Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1092 in Healthy Subjects (HS)
    Morrow, Linda
    Grimm, Michael
    Beysen, Carine
    Walford, Geoffrey
    Duncan, Kelly
    Mitra, Pranab K.
    Vaddady, Pavan
    Hompesch, Marcus
    DIABETES, 2020, 69
  • [7] A PHASE 1, SINGLE AND MULTIPLE ASCENDING DOSE STUDY OF SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF AG-519, AN ALLOSTERIC ACTIVATOR OF PYRUVATE KINASE-R IN HEALTHY SUBJECTS
    Barbier, A.
    Cutie, J.
    Connor, G.
    Merica, E.
    Kung, C.
    Le, K.
    Yang, H.
    Kosinski, P. A.
    Silverman, L.
    Yuan, Z. J.
    Agresta, S.
    Cohen, M.
    HAEMATOLOGICA, 2016, 101 : 301 - 301
  • [8] A Randomized, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Insulin Dimer
    Walford, Geoffrey A.
    Duncan, Kelly E.
    Hernandez, Moises
    Vaddady, Pavan
    Hompesch, Marcus
    Morrow, Linda
    Stoch, S. Aubrey
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (01) : 125 - 132
  • [9] A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers
    Susanne Johansson
    David P. Rosenbaum
    Mikael Knutsson
    Maria Leonsson-Zachrisson
    Clinical and Experimental Nephrology, 2017, 21 : 407 - 416
  • [10] Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers
    Al-Karagholi, Mohammad Al-Mandi
    Hansen, Jakob Moller
    Abou-Kassem, Dalia
    Hansted, Anna Koldbro
    Ubhayasekera, Kumari
    Bergquist, Jonas
    Vecsei, Laszlo
    Jansen-Olesen, Inger
    Ashina, Messoud
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (02):